Mefunidone was shown to reduce the expression of Snail and vimentin by inhibiting the transduction of the TGF-β/Smad2 signaling pathway and the activation of the MAPK pathway, thereby inhibiting the process of EMT and improving pulmonary fibrosis [61]. Here, SMAD2 is linked to pulmonary fibrosis.